RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Horselover, Concerning the Euro patent challenge, I don't have the exact dates, but it seems like it's been several years since Glaxo joined the challenge, and Lilly was challenging for several years before that (losing in their first attempt). Neuro probably has more precise dates.

There was a guy over on Yahoo ("Orange45" I think) who was very knowledgeable about bio patents, though I couldn't seem to locate his posts on Yahoo with the busyant function.

It seems like it's been around 1.5-2 years since we discussed Glaxo entering the picture, and at that time there were guestimates that a resolution might take perhaps 2-5 years. Dr. Stoll discussed the topic several times back then, and basically said that there was no way to accurately estimate when a resolution would come. When the Euro patent was upheld the first time around, the news came out of the blue, and the stock moved up dramatically.

It's apparently easier to challenge patents in Europe than in the US, which is presumably why Lilly challenged there. They might conceivably try to challenge in the US someday, or perhaps go after a different patent, like the neurotrophin upregulation broad use patent.